Overview

Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate and compare the effects of intravenous and topical administration of tranexamic acid during revision hip arthroplasty on blood loss, allogenic blood transfusion rates, length of hospital stay and perioperative complications.
Phase:
Phase 4
Details
Lead Sponsor:
Mount Sinai Hospital, Canada
Treatments:
Tranexamic Acid